| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometriosis | 17 | 2025 | 81 | 7.220 |
Why?
|
| Colitis | 19 | 2025 | 69 | 4.020 |
Why?
|
| Colon | 17 | 2025 | 118 | 3.050 |
Why?
|
| Intestinal Mucosa | 9 | 2025 | 131 | 2.210 |
Why?
|
| Stress, Psychological | 7 | 2020 | 641 | 2.130 |
Why?
|
| Probiotics | 5 | 2025 | 37 | 1.960 |
Why?
|
| Macrophages | 6 | 2025 | 515 | 1.810 |
Why?
|
| Inflammatory Bowel Diseases | 7 | 2017 | 101 | 1.800 |
Why?
|
| Vitamin D | 3 | 2025 | 196 | 1.800 |
Why?
|
| Disease Models, Animal | 26 | 2025 | 1554 | 1.780 |
Why?
|
| Rats, Sprague-Dawley | 31 | 2024 | 1737 | 1.770 |
Why?
|
| Receptors, Calcitriol | 4 | 2020 | 69 | 1.610 |
Why?
|
| Rats | 37 | 2025 | 3701 | 1.480 |
Why?
|
| Pyrroles | 2 | 2020 | 68 | 1.200 |
Why?
|
| Inflammation | 5 | 2024 | 729 | 1.170 |
Why?
|
| Trinitrobenzenesulfonic Acid | 15 | 2025 | 20 | 1.170 |
Why?
|
| Pyrimidines | 2 | 2020 | 130 | 1.140 |
Why?
|
| Animals | 47 | 2025 | 16695 | 1.130 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 4 | 2022 | 26 | 1.060 |
Why?
|
| Neutrophil Infiltration | 2 | 2025 | 28 | 1.050 |
Why?
|
| Physiology | 2 | 2018 | 17 | 0.970 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2024 | 14 | 0.890 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2024 | 74 | 0.890 |
Why?
|
| Colorectal Neoplasms | 3 | 2016 | 502 | 0.870 |
Why?
|
| Neuroglia | 1 | 2024 | 131 | 0.850 |
Why?
|
| Pituitary-Adrenal System | 3 | 2020 | 41 | 0.820 |
Why?
|
| Colonic Neoplasms | 3 | 2011 | 223 | 0.820 |
Why?
|
| Students | 3 | 2023 | 617 | 0.820 |
Why?
|
| Uterus | 3 | 2020 | 57 | 0.800 |
Why?
|
| Faculty | 1 | 2023 | 105 | 0.780 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2020 | 34 | 0.770 |
Why?
|
| Inflammation Mediators | 5 | 2020 | 138 | 0.750 |
Why?
|
| Female | 29 | 2025 | 24018 | 0.720 |
Why?
|
| Disease Progression | 5 | 2018 | 661 | 0.720 |
Why?
|
| Receptors, Neurokinin-1 | 4 | 2017 | 25 | 0.710 |
Why?
|
| Crohn Disease | 2 | 2016 | 69 | 0.670 |
Why?
|
| Colitis, Ulcerative | 2 | 2016 | 68 | 0.670 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2020 | 55 | 0.650 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2020 | 15 | 0.640 |
Why?
|
| Adrenal Glands | 1 | 2020 | 17 | 0.640 |
Why?
|
| Gastrointestinal Motility | 3 | 2014 | 20 | 0.630 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 928 | 0.620 |
Why?
|
| Receptors, Opioid, mu | 2 | 2017 | 50 | 0.610 |
Why?
|
| Biomedical Research | 2 | 2015 | 467 | 0.610 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 2024 | 126 | 0.600 |
Why?
|
| Ethanol | 5 | 2024 | 221 | 0.590 |
Why?
|
| Behavior, Animal | 3 | 2025 | 369 | 0.590 |
Why?
|
| Professional Role | 1 | 2018 | 40 | 0.570 |
Why?
|
| Thinking | 1 | 2018 | 36 | 0.570 |
Why?
|
| Endometrium | 2 | 2020 | 60 | 0.570 |
Why?
|
| Teaching | 1 | 2018 | 58 | 0.570 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2017 | 8 | 0.560 |
Why?
|
| Housing, Animal | 1 | 2017 | 12 | 0.560 |
Why?
|
| Receptor, trkA | 1 | 2017 | 6 | 0.560 |
Why?
|
| Nerve Growth Factor | 1 | 2017 | 28 | 0.550 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 136 | 0.550 |
Why?
|
| Neurogenesis | 1 | 2017 | 64 | 0.530 |
Why?
|
| Receptors, Tachykinin | 2 | 2007 | 2 | 0.520 |
Why?
|
| Pain Threshold | 1 | 2017 | 34 | 0.520 |
Why?
|
| Career Choice | 2 | 2018 | 51 | 0.510 |
Why?
|
| Environment | 1 | 2017 | 148 | 0.510 |
Why?
|
| Male | 32 | 2025 | 22779 | 0.510 |
Why?
|
| Periaqueductal Gray | 1 | 2016 | 11 | 0.500 |
Why?
|
| Quality of Life | 1 | 2021 | 599 | 0.500 |
Why?
|
| Stress, Physiological | 1 | 2017 | 170 | 0.490 |
Why?
|
| Paraffin Embedding | 1 | 2015 | 13 | 0.480 |
Why?
|
| Tissue Fixation | 1 | 2015 | 18 | 0.480 |
Why?
|
| Formaldehyde | 1 | 2015 | 30 | 0.480 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 133 | 0.470 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 196 | 0.460 |
Why?
|
| Biological Specimen Banks | 2 | 2025 | 28 | 0.460 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 107 | 0.450 |
Why?
|
| Uterine Contraction | 1 | 2014 | 6 | 0.440 |
Why?
|
| Substance P | 3 | 2017 | 26 | 0.440 |
Why?
|
| Educational Measurement | 1 | 2015 | 100 | 0.430 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 301 | 0.420 |
Why?
|
| Medical Oncology | 1 | 2014 | 46 | 0.420 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 2022 | 48 | 0.410 |
Why?
|
| Quinuclidines | 2 | 2010 | 4 | 0.410 |
Why?
|
| Gene Expression Profiling | 2 | 2007 | 683 | 0.400 |
Why?
|
| Piperidines | 2 | 2010 | 80 | 0.390 |
Why?
|
| Documentation | 1 | 2012 | 18 | 0.390 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2005 | 379 | 0.390 |
Why?
|
| Humans | 22 | 2025 | 42163 | 0.380 |
Why?
|
| Career Mobility | 1 | 2012 | 29 | 0.380 |
Why?
|
| Education, Graduate | 1 | 2012 | 30 | 0.380 |
Why?
|
| Education, Medical | 1 | 2014 | 117 | 0.380 |
Why?
|
| Puerto Rico | 5 | 2016 | 1376 | 0.370 |
Why?
|
| Lactobacillus | 2 | 2011 | 22 | 0.360 |
Why?
|
| Quinazolines | 1 | 2011 | 37 | 0.360 |
Why?
|
| Precancerous Conditions | 1 | 2011 | 83 | 0.340 |
Why?
|
| Pain Measurement | 2 | 2025 | 181 | 0.340 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 159 | 0.330 |
Why?
|
| Cytokines | 3 | 2025 | 661 | 0.330 |
Why?
|
| Chronic Disease | 6 | 2017 | 541 | 0.320 |
Why?
|
| Acute Disease | 6 | 2017 | 156 | 0.320 |
Why?
|
| Endometritis | 1 | 2007 | 2 | 0.280 |
Why?
|
| Corticosterone | 4 | 2017 | 89 | 0.280 |
Why?
|
| Valine | 1 | 2007 | 29 | 0.270 |
Why?
|
| Tetrazoles | 1 | 2007 | 45 | 0.270 |
Why?
|
| Colony Count, Microbial | 2 | 2007 | 67 | 0.270 |
Why?
|
| Communication | 2 | 2023 | 207 | 0.260 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 979 | 0.260 |
Why?
|
| Acetylcholine | 1 | 2006 | 76 | 0.240 |
Why?
|
| Gastric Mucosa | 2 | 2005 | 64 | 0.240 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2005 | 5 | 0.240 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 38 | 0.240 |
Why?
|
| Myenteric Plexus | 1 | 2024 | 2 | 0.230 |
Why?
|
| Enteric Nervous System | 1 | 2024 | 2 | 0.230 |
Why?
|
| Biopsy | 2 | 2016 | 176 | 0.230 |
Why?
|
| Antihypertensive Agents | 1 | 2007 | 285 | 0.230 |
Why?
|
| Gliosis | 1 | 2024 | 25 | 0.230 |
Why?
|
| Mice | 4 | 2025 | 6490 | 0.210 |
Why?
|
| Platelet Activating Factor | 2 | 1995 | 9 | 0.210 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2016 | 184 | 0.210 |
Why?
|
| Dietary Supplements | 1 | 2025 | 208 | 0.210 |
Why?
|
| Time Factors | 5 | 2014 | 1848 | 0.210 |
Why?
|
| Phosphorylation | 2 | 2017 | 973 | 0.200 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 61 | 0.200 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2007 | 147 | 0.200 |
Why?
|
| Hippocampus | 2 | 2019 | 591 | 0.200 |
Why?
|
| Neoplasms | 1 | 2014 | 1341 | 0.190 |
Why?
|
| Gene Expression Regulation | 2 | 2007 | 1066 | 0.190 |
Why?
|
| Blood Vessels | 1 | 2002 | 36 | 0.190 |
Why?
|
| Pain | 1 | 2025 | 283 | 0.190 |
Why?
|
| Case-Control Studies | 2 | 2016 | 1266 | 0.190 |
Why?
|
| Anxiety | 3 | 2022 | 847 | 0.180 |
Why?
|
| Blood-Brain Barrier | 2 | 2019 | 167 | 0.170 |
Why?
|
| Metagenome | 2 | 2011 | 31 | 0.170 |
Why?
|
| RNA, Messenger | 4 | 2020 | 1265 | 0.170 |
Why?
|
| Middle Aged | 6 | 2024 | 11819 | 0.170 |
Why?
|
| Metabolomics | 1 | 2021 | 90 | 0.170 |
Why?
|
| Bacterial Proteins | 1 | 2005 | 580 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 1804 | 0.160 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2019 | 13 | 0.160 |
Why?
|
| Bacteria | 1 | 2003 | 285 | 0.160 |
Why?
|
| Stomach Diseases | 2 | 1997 | 5 | 0.160 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 53 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2011 | 180 | 0.150 |
Why?
|
| Enzyme Inhibitors | 2 | 2020 | 457 | 0.150 |
Why?
|
| Haptens | 2 | 1995 | 20 | 0.150 |
Why?
|
| Job Description | 1 | 2018 | 6 | 0.150 |
Why?
|
| Adult | 5 | 2024 | 13458 | 0.150 |
Why?
|
| Peroxidase | 3 | 2007 | 57 | 0.140 |
Why?
|
| Models, Educational | 1 | 2018 | 46 | 0.140 |
Why?
|
| Urocortins | 1 | 2017 | 4 | 0.140 |
Why?
|
| Receptors, Growth Factor | 1 | 2017 | 12 | 0.140 |
Why?
|
| Astrocytes | 1 | 2019 | 244 | 0.140 |
Why?
|
| Recurrence | 3 | 2005 | 149 | 0.130 |
Why?
|
| Aged | 4 | 2016 | 7982 | 0.130 |
Why?
|
| Up-Regulation | 1 | 2020 | 534 | 0.130 |
Why?
|
| Enkephalins | 1 | 2017 | 29 | 0.130 |
Why?
|
| Receptors, Neurokinin-2 | 2 | 2007 | 2 | 0.130 |
Why?
|
| Program Evaluation | 1 | 2018 | 358 | 0.130 |
Why?
|
| Feces | 1 | 2017 | 126 | 0.130 |
Why?
|
| Enkephalin, Methionine | 1 | 2016 | 7 | 0.130 |
Why?
|
| Enkephalin, Leucine | 1 | 2016 | 4 | 0.130 |
Why?
|
| Prevalence | 2 | 2016 | 1597 | 0.130 |
Why?
|
| beta-Endorphin | 1 | 2016 | 16 | 0.120 |
Why?
|
| Oligopeptides | 1 | 2017 | 108 | 0.120 |
Why?
|
| Spinal Cord | 1 | 2017 | 109 | 0.120 |
Why?
|
| Curriculum | 1 | 2018 | 311 | 0.120 |
Why?
|
| Cell Lineage | 1 | 2016 | 104 | 0.120 |
Why?
|
| Leukocytes | 1 | 1996 | 79 | 0.120 |
Why?
|
| Staining and Labeling | 1 | 2015 | 106 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 382 | 0.110 |
Why?
|
| School Admission Criteria | 1 | 2015 | 10 | 0.110 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 173 | 0.110 |
Why?
|
| Fellowships and Scholarships | 1 | 2015 | 32 | 0.110 |
Why?
|
| Homeostasis | 1 | 2016 | 193 | 0.110 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 279 | 0.110 |
Why?
|
| Defecation | 1 | 2014 | 6 | 0.110 |
Why?
|
| Benzodiazepines | 2 | 2024 | 19 | 0.110 |
Why?
|
| Young Adult | 2 | 2016 | 4936 | 0.110 |
Why?
|
| Cyclooxygenase 2 | 1 | 2015 | 106 | 0.110 |
Why?
|
| Leukocyte Count | 2 | 2012 | 68 | 0.110 |
Why?
|
| Demography | 1 | 2015 | 195 | 0.110 |
Why?
|
| Treatment Outcome | 1 | 2018 | 1586 | 0.110 |
Why?
|
| Maze Learning | 1 | 2014 | 112 | 0.110 |
Why?
|
| Phenotype | 1 | 2016 | 774 | 0.100 |
Why?
|
| Job Application | 1 | 2012 | 3 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2016 | 633 | 0.100 |
Why?
|
| Indomethacin | 2 | 2007 | 26 | 0.100 |
Why?
|
| Organizational Objectives | 1 | 2012 | 33 | 0.100 |
Why?
|
| Professional Competence | 1 | 2012 | 42 | 0.100 |
Why?
|
| Staff Development | 1 | 2012 | 30 | 0.100 |
Why?
|
| Writing | 1 | 2012 | 41 | 0.100 |
Why?
|
| Ascitic Fluid | 1 | 2012 | 7 | 0.100 |
Why?
|
| Neurons | 1 | 2019 | 1246 | 0.090 |
Why?
|
| Rabbits | 3 | 2002 | 292 | 0.090 |
Why?
|
| Swimming | 1 | 2012 | 40 | 0.090 |
Why?
|
| Angiostatins | 1 | 2011 | 2 | 0.090 |
Why?
|
| Endostatins | 1 | 2011 | 5 | 0.090 |
Why?
|
| Bifidobacterium | 1 | 2011 | 4 | 0.090 |
Why?
|
| Mast Cells | 1 | 2012 | 83 | 0.090 |
Why?
|
| Streptococcus | 1 | 2011 | 18 | 0.090 |
Why?
|
| Alkaline Phosphatase | 1 | 2011 | 53 | 0.090 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 410 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 136 | 0.090 |
Why?
|
| Alcoholism | 2 | 2024 | 292 | 0.090 |
Why?
|
| Child | 1 | 2018 | 3381 | 0.080 |
Why?
|
| Rats, Wistar | 5 | 2001 | 282 | 0.080 |
Why?
|
| Calcium | 1 | 1992 | 487 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 165 | 0.080 |
Why?
|
| E-Selectin | 2 | 2005 | 23 | 0.080 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2005 | 58 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2010 | 884 | 0.070 |
Why?
|
| 1,2-Dimethylhydrazine | 1 | 2007 | 1 | 0.070 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2007 | 9 | 0.070 |
Why?
|
| Cell Line | 1 | 2011 | 1416 | 0.070 |
Why?
|
| Muscle Contraction | 1 | 2007 | 67 | 0.070 |
Why?
|
| Neurokinin A | 1 | 2007 | 1 | 0.070 |
Why?
|
| Receptors, Neurokinin-3 | 1 | 2007 | 1 | 0.070 |
Why?
|
| Glucocorticoids | 2 | 1999 | 92 | 0.070 |
Why?
|
| Exons | 1 | 2007 | 91 | 0.070 |
Why?
|
| Tetrodotoxin | 1 | 2007 | 23 | 0.070 |
Why?
|
| Stomach | 2 | 1999 | 50 | 0.070 |
Why?
|
| Anesthetics, Local | 1 | 2007 | 20 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2016 | 2111 | 0.060 |
Why?
|
| Stereoisomerism | 1 | 2007 | 166 | 0.060 |
Why?
|
| Neurotransmitter Agents | 1 | 2007 | 69 | 0.060 |
Why?
|
| Carcinoma | 1 | 2007 | 106 | 0.060 |
Why?
|
| Benzamides | 1 | 2007 | 78 | 0.060 |
Why?
|
| Naproxen | 2 | 1997 | 10 | 0.060 |
Why?
|
| Antipsychotic Agents | 1 | 2007 | 81 | 0.060 |
Why?
|
| Tissue Culture Techniques | 1 | 2006 | 36 | 0.060 |
Why?
|
| Muscle, Smooth | 1 | 2006 | 59 | 0.060 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2005 | 4 | 0.060 |
Why?
|
| Intestine, Small | 1 | 2005 | 25 | 0.060 |
Why?
|
| Intestinal Diseases | 1 | 2005 | 6 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2005 | 22 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2005 | 12 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 310 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1420 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 233 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 649 | 0.060 |
Why?
|
| Hormone Antagonists | 2 | 2022 | 13 | 0.060 |
Why?
|
| Perioperative Care | 1 | 2024 | 10 | 0.060 |
Why?
|
| Alcohol Withdrawal Delirium | 1 | 2024 | 3 | 0.060 |
Why?
|
| State Medicine | 1 | 2024 | 9 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 602 | 0.050 |
Why?
|
| Probability | 1 | 2004 | 82 | 0.050 |
Why?
|
| Age of Onset | 1 | 2004 | 115 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2024 | 256 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2004 | 224 | 0.050 |
Why?
|
| Age Distribution | 1 | 2004 | 249 | 0.050 |
Why?
|
| Dextran Sulfate | 1 | 2003 | 17 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 59 | 0.050 |
Why?
|
| United States | 1 | 2014 | 5072 | 0.050 |
Why?
|
| Length of Stay | 1 | 2024 | 231 | 0.050 |
Why?
|
| Thromboxane B2 | 1 | 2002 | 9 | 0.050 |
Why?
|
| Radioimmunoassay | 1 | 2002 | 70 | 0.050 |
Why?
|
| Mutation | 1 | 2007 | 1169 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2004 | 574 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2002 | 69 | 0.050 |
Why?
|
| Gene Expression | 1 | 2005 | 692 | 0.050 |
Why?
|
| Models, Animal | 1 | 2003 | 149 | 0.050 |
Why?
|
| Microspheres | 2 | 1999 | 49 | 0.050 |
Why?
|
| Bacterial Translocation | 1 | 2001 | 2 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 708 | 0.040 |
Why?
|
| Prognosis | 1 | 2004 | 850 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2004 | 845 | 0.040 |
Why?
|
| Indazoles | 1 | 2020 | 10 | 0.040 |
Why?
|
| Pyridones | 1 | 2020 | 50 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2004 | 1574 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 74 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2004 | 1729 | 0.040 |
Why?
|
| Tin | 1 | 1999 | 1 | 0.040 |
Why?
|
| Scandium | 1 | 1999 | 2 | 0.040 |
Why?
|
| Radioisotopes | 1 | 1999 | 17 | 0.040 |
Why?
|
| Liver Diseases | 1 | 1999 | 34 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 319 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 1999 | 86 | 0.040 |
Why?
|
| Liver Cirrhosis, Experimental | 1 | 1997 | 2 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2024 | 2485 | 0.030 |
Why?
|
| Cholestasis | 1 | 1997 | 11 | 0.030 |
Why?
|
| Peptic Ulcer | 1 | 1997 | 15 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 2803 | 0.030 |
Why?
|
| Analgesics | 1 | 1997 | 55 | 0.030 |
Why?
|
| Stomach Ulcer | 1 | 1996 | 8 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1996 | 30 | 0.030 |
Why?
|
| Dinitrochlorobenzene | 1 | 1995 | 1 | 0.030 |
Why?
|
| Benzenesulfonates | 1 | 1995 | 9 | 0.030 |
Why?
|
| Chymases | 1 | 1995 | 3 | 0.030 |
Why?
|
| Liver | 1 | 1999 | 503 | 0.030 |
Why?
|
| Animal Feed | 1 | 1996 | 50 | 0.030 |
Why?
|
| Glyceryl Ethers | 1 | 1995 | 1 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 1617 | 0.030 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 1995 | 4 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1995 | 26 | 0.030 |
Why?
|
| Chromatography, Thin Layer | 1 | 1995 | 39 | 0.030 |
Why?
|
| Azepines | 1 | 1995 | 22 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 1995 | 48 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 1996 | 237 | 0.030 |
Why?
|
| Depression | 1 | 2022 | 837 | 0.030 |
Why?
|
| Triazoles | 1 | 1995 | 100 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1995 | 458 | 0.020 |
Why?
|
| Adolescent | 1 | 2004 | 5950 | 0.020 |
Why?
|
| Phenylmethylsulfonyl Fluoride | 1 | 1992 | 3 | 0.020 |
Why?
|
| Cell Movement | 1 | 1996 | 640 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2005 | 3 | 0.020 |
Why?
|
| Peritoneum | 1 | 2005 | 9 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2005 | 16 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2005 | 21 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2005 | 32 | 0.010 |
Why?
|
| Solubility | 1 | 2005 | 134 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 452 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 2001 | 2 | 0.010 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2001 | 14 | 0.010 |
Why?
|
| Bacteria, Aerobic | 1 | 2001 | 7 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 2001 | 132 | 0.010 |
Why?
|
| Mucus | 1 | 2001 | 15 | 0.010 |
Why?
|
| Permeability | 1 | 2001 | 66 | 0.010 |
Why?
|
| Enterotoxins | 1 | 2001 | 33 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 2001 | 50 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2001 | 128 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2001 | 134 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 314 | 0.010 |
Why?
|
| Fluorescein | 1 | 1999 | 18 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1999 | 25 | 0.010 |
Why?
|
| Acetic Acid | 1 | 1999 | 19 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1999 | 36 | 0.010 |
Why?
|
| Dextrans | 1 | 1999 | 28 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1999 | 37 | 0.010 |
Why?
|
| Carbon Tetrachloride | 1 | 1999 | 3 | 0.010 |
Why?
|
| Adrenalectomy | 1 | 1999 | 23 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 1999 | 72 | 0.010 |
Why?
|
| Mifepristone | 1 | 1999 | 34 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1999 | 362 | 0.010 |
Why?
|
| Immune Sera | 1 | 1997 | 56 | 0.010 |
Why?
|
| Ileal Diseases | 1 | 1997 | 2 | 0.010 |
Why?
|
| Pentoxifylline | 1 | 1997 | 6 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1997 | 30 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1997 | 27 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1999 | 662 | 0.010 |
Why?
|
| Neutrophils | 1 | 1995 | 141 | 0.010 |
Why?
|
| Brain | 1 | 1999 | 1452 | 0.010 |
Why?
|